Skip to main content
logo
TMX Group Limited (TSX:X)
Canada flag Canada · Delayed Price · Currency is CAD
56.57
+0.34 (0.60%)
Jul 31, 2025, 10:00 AM EDT

Achilles Therapeutics Revenue

TMX Group had revenue of 419.10M CAD in the quarter ending March 31, 2025, with 21.16% growth. This brings the company's revenue in the last twelve months to 1.53B, up 23.56% year-over-year. In the year 2024, TMX Group had annual revenue of 1.46B with 22.28% growth.

Revenue (ttm)
1.53B
Revenue Growth
+23.56%
P/S Ratio
10.20
Revenue / Employee
751.99K
Employees
1,803
Market Cap
15.64B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.46B266.00M22.28%
Dec 31, 20231.19B79.20M7.10%
Dec 31, 20221.11B134.20M13.68%
Dec 31, 2021980.70M115.60M13.36%
Dec 31, 2020865.10M58.20M7.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Royal Bank of Canada58.14B
The Toronto-Dominion Bank62.22B
Brookfield120.17B
Brookfield Asset Management6.00B
Bank of Montreal30.60B
The Bank of Nova Scotia29.18B
Canadian Imperial Bank of Commerce25.44B
Manulife Financial30.02B
Revenue Rankings

TMX Group News

More News